Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation

Pharmaceutical Research

Volumn 15, Issue 5, 1998, Pages 706-711

  Piquette Miller, Micheline ^a   Pak, Anne ^b   Kim, Hani ^a   Anari, Reza ^a   Shahzamani, Afshin ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

Acute phase response; Drug disposition; Gene regulation; Inflammation; Multidrug resistance; P glycoprotein

Indexed keywords

GLYCOPROTEIN P; LIVER PROTEIN; MESSENGER RNA; RHODAMINE; RIBONUCLEASE; VERAPAMIL;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; FEMALE; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; IMMUNOBLOTTING; INFLAMMATION; LIVER FUNCTION; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT;

ACUTE DISEASE; ACUTE-PHASE REACTION; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG RESISTANCE, MULTIPLE; FEMALE; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER; MALE; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY; RHODAMINE 123; RHODAMINES; RNA, MESSENGER;

EID: 0031750862     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011962818051     Document Type: Article

References (29)

1. R. E. Schneider, J. Babb, H. Bishop, and M. Mitchard. Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease. Br. Med. J. 2:794-795 (1976).
2. F. M. Belpaire, F. De Smet, B. Chindavijak, N. Fraeyman, and M. G. Bogaert. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat. Fund. Clin. Pharmacol. 3:79-88 (1989).
3. M. Piquette-Miller and F. Jamali. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats. Pharm. Res. 10:294-299 (1993).
4. Acute Phase Proteins: molecular biology, biochemistry & clinical Applications (A. Mackiewicz & I. Krushner, eds.), CRC Press Inc., Boca Raton, (1993).
5. E. T. Morgan. Suppression of constitutive P450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol. Pharmacol. 36:699-707 (1989).
6. K. A. Walker, H. Barber, and G. Hanksworth. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat. Drug Metab. Dispos. 14:482-486 (1986).
7. S. E. Kane, I. Pastan, and M. M. Gottesman. Mini-review: genetic basis of multidrug resistance of tumor cells. J. Bioenerg. Biomem. 22:593-618 (1990).
8. P. F. Juranka, R. L. Zastawny, and V. Ling. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB. 3:2583-92 (1989).
9. J. J. M. Smit, A. H. Schninkel, R. P. Elferink et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451-462 (1993).
10. T. W. Gant, J. A. Silverman, H. C. Bisgaard, R. K. Burt, P. A. Marino, and S. S. Thorgeirsson. Regulation of 2-acetylaminofluorene-and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450 1A gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcin. 4:499-59 (1991).
11. K. V. Chin, S. Tanaka, G. Darlington, I. Pastan, and M. M. Gottesman. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265:221-226 (1990).
12. B. T. Hill, K. L. Deuchars, L. K. Hosking, V. Ling, and R. D. Whelan. Overexpression of P-glycoprotein in mammalian tumor cells lines after fractionated X irradiation in vitro. J. Natl. Cancer Inst. 82:607-612 (1990).
13. G. Schreiber, A. R. Aldred, T. Thomas et al. Levels of mRNA for plasma proteins in rat liver during acute experimental inflammation. Inflammation 10:59-67 (1986).
14. J. Milland, A. Tsykin, T. Thomas, A. R. Aldred, T. Cole, and G. Schreiber. Gene expression in regenerating and acute-phase rat liver. Am. J. Physiol. 259:G340-7 (1990).
15. G. Fantuzzi and C. A. Dinarello. The inflammatory response in IL-1-β-deficient mice: comparison with other cytokine-related knock-out mice. J. Leukocyte Biol. 59:489-93 (1996).
16. P. Moldeus, J. Hogberg, and S. Orrenius. Isolation and use of liver cells. Methods Enzymol. 52:60-70 (1978).
17. P. C. Brown, S. S. Thorgeirsson, and J. A. Silverman. Cloning and regulation of the rat mdr2 gene. Nucleic Acids Res. 21:3885-91 (1993).
18. E. Chieli, E. Santoni Rugiu, F. Cervelli, A. Paolicchi, and R. Tongiani. Assessment of P-glycoprotein dependent drug transport in isolated rat hepatocytes using rhodamine 123. Cell Biol. Toxicol. 9:235-42 (1993).
19. A. H. Schinkel, U. Mayer, E. Wagenaar et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl Acad. Sci. USA 94:4028-33 (1997).
20. E. T. Morgan, K. B. Thomas, R. Swanson, T. Vales, J. Hwang, and K. Wright. Selective suppression of cytochrome P450 gene expression by IL-1 and IL-6 in rat liver. Biochim. Biophys. Acta 1219:475-483 (1994).
21. M. Trauner, M. Arrese, C. J. Soroka et al. The rat canalicular conjugate export pump (Mrp2) is downregulated in intrahepatic and obstructive cholestasis. Gastroent. 113:255-264 (1997).
22. H-D. Flad, H. Loppnow, E. T. Rietschel, and A. J. Ulmer. Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiol. 187:303-316 (1993).
23. W. Walther and U. Stein. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J. Cancer Res. Clin. Oncol. 120:471-478 (1994).
24. N. J. Combates, R. W. Rzepka, Y. N. P. Chen, and D. Cohen. NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human mdr1 gene promoter. J.Biol. Chem. 269:29715-9 (1994).
25. J. J. M. Smit, C. A. Mol, L. Van Deemter, E. Wagenaar, A. H. Schninkel, and P. Borst. Characterization of the promoter region of the human MDR3 P-glycoprotein gene. Biochim. Biophys. Acta. 1261:44-56 (1995).
26. C. H. Lee, G. Bradley, and V. Ling. Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability. Cell Growth & Differentiation 6:347-54 (1995).
27. J. Drach, A. Gsur, G. Hamilton et al. Involvement of P-gp in the transmembrane transport of IL-2, IL-4 and IFN-γ in normal human T-lymphocytes. Blood 88:1747-54 (1996).
28. E. G. Schuetz, W. T. Beck, and J. D. Schuetz. Modulators and substrates of P-glycoprotein and cytochrome P450 3A coordinately upregulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49:311-318 (1996).
29. K. N. Furuya, R. Gebhardt, E. G. Schuetz, and J. D. Schuetz. Isolation of rat p-glycoprotein3 cDNA: evidence for gender and zonal regulation of expression in the liver. Biochim. Biophys. Acta. 1219:636-644 (1994).